Genetic Abnormalities in Extramedullary Multiple Myeloma

Genetic Abnormalities in Extramedullary Multiple Myeloma

Extramedullary multiple myeloma (or extramedullary disease, EMD) is an aggressive form of multiple myeloma (MM) that occurs when malignant plasma cells become independent of the bone marrow microenvironment. This may occur alongside MM diagnosis or in later stages of relapse and confers an extremely...

Full description

Bibliographic Details
Main Authors:	Roisin McAvera, John Quinn, Philip Murphy, Siobhan Glavey
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	International Journal of Molecular Sciences
Subjects:	extramedullary myeloma genomics high-risk multiple myeloma
Online Access:	https://www.mdpi.com/1422-0067/24/14/11259

Similar Items

Advances in the treatment of extramedullary disease in multiple myeloma
by: Yating Li, et al.
Published: (2022-08-01)

A rare case of bifocal, extramedullary and hyposecretory relapse of multiple myeloma
by: Jiri Minarik, et al.
Published: (2021-08-01)

Pomalidomide-based therapy for extramedullary multiple myeloma
by: Yating Li, et al.
Published: (2022-12-01)

Incidence of Extramedullary Myeloma in Multiple Myeloma Patients
by: Sinan Demircioğlu, et al.
Published: (2019-07-01)

Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma
by: JingSong He, et al.
Published: (2021-07-01)

Isolated Non-Secretory Extramedullary Relapse of Multiple Myeloma Responded Completely to Localized Radiotherapy
by: Danny Dawd, et al.
Published: (2024-03-01)

Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease
by: Ja Min Byun, et al.
Published: (2022-10-01)

A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?
by: Uros Markovic, et al.
Published: (2019-09-01)

Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures
by: Katie Dunphy, et al.
Published: (2023-07-01)

Relapse of multiple myeloma presenting as extramedullary plasmacytoma surrounding the aorta: A rare case report
by: Omer Ekinci, et al.
Published: (2020-12-01)

Multiple myeloma with extramedullary plasmacytoma: pathogenesis and clinical case
by: M. V. Firsova, et al.
Published: (2022-11-01)

Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease
by: Xiang Zhou, et al.
Published: (2020-04-01)

Editorial: Molecular Mechanisms of Multiple Myeloma
by: Alessandro Gozzetti, et al.
Published: (2022-03-01)

Solitary Extramedullary Plasmacytoma of the Larynx and Secondary Laryngeal Involvement in Plasma Cell Myeloma: Single-Centre Retrospective Analysis and Systematic Literature Review
by: Elżbieta Szczepanek, et al.
Published: (2022-07-01)

Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease
by: Al‐Ola Abdallah, et al.
Published: (2021-11-01)

Hypersialylation and multiple myeloma
by: Michael O’Dwyer, et al.
Published: (2024-02-01)

Survival trends and prognostic factors of patients with newly diagnosed multiple myeloma accompanied with extramedullary disease
by: Jing Wang, et al.
Published: (2023-12-01)

Secondary extramedullary plasmacytoma of sigmoid colon in a patient with multiple myeloma: a case report
by: Dimitris Fagkrezos, et al.
Published: (2018-12-01)

Identification of long noncoding RNA NEAT1 as a key gene involved in the extramedullary disease of multiple myeloma by bioinformatics analysis
by: Ting Chen, et al.
Published: (2023-12-01)

Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical Guidance
by: Vincenzo Sammartano, et al.
Published: (2022-07-01)

Multiple myeloma presenting as CEA-producing rectal cancer
by: Giampaolo Talamo
Published: (2010-03-01)

Extramedullary relapse of multiple myeloma defined as the highest risk group based on deregulated gene expression data
by: Sabina Sevcikova, et al.
Published: (2015-06-01)

Integrated Transcriptomic Analysis Reveals a Distinctive Role of YAP1 in Extramedullary Invasion and Therapeutic Sensitivity of Multiple Myeloma
by: Bo Zheng, et al.
Published: (2022-01-01)

Multiple Myeloma with Ovarian Plasmacytoma Mimicking Ovarian Carcinoma with Metastasis: A Case Report
by: Shivangi Agarwal, et al.
Published: (2021-05-01)

Extramedullary Plasmacytoma of Soft Tissues and Gingiva
by: Amrit Kaur Kaler, et al.
Published: (2012-07-01)

Multiple Myeloma with Hypoechoic Liver Nodules
by: Mathilde Duesberg, et al.
Published: (2019-10-01)

A Case Report of Extramedullary Myeloma Mimicking Lymphoma with Extensive Abdominal Involvement
by: Jihae Moon, et al.
Published: (2019-09-01)

Extramedullary Plasmacytoma in the Maxillary Sinus
by: Jennifer De Silva-Leonardo, et al.
Published: (2009-11-01)

Duodenal Ulcer with Massive Gastrointestinal Hemorrhage as an Initial Manifestation in Multiple Myeloma with Extramedullary Disease: A Case Report
by: Hao-Tse Chiu, et al.
Published: (2022-01-01)

Efficacy of Bendamustine, Pomalidomide, and Dexamethasone (BPD) Regimen in Relapsed/Refractory Extramedullary Myeloma: A Retrospective Single-Centre Study, Real-Life Experience
by: İbrahim Halil Açar, et al.
Published: (2023-08-01)

Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma
by: Juan Xu, et al.
Published: (2021-06-01)

Apical lung mass—A rare presentation of multiple myeloma
by: Tobechukwu Joseph Okobi, MD, Msc, et al.
Published: (2022-09-01)

A prognostic model for patients with primary extramedullary multiple myeloma
by: Limei Zhang, et al.
Published: (2022-11-01)

Doxorubicin-Loaded PEG-CdTe Quantum Dots as a Smart Drug Delivery System for Extramedullary Multiple Myeloma Treatment
by: Dangui Chen, et al.
Published: (2018-11-01)

Plasmacytoma of the testis in a patient with relapsed and refractory multiple myeloma: Case report and review of the literature
by: Munad Khan, et al.
Published: (2015-01-01)

Analysis of High-Risk Extramedullary Relapse Factors in Newly Diagnosed MM Patients
by: Xiaoyan Yue, et al.
Published: (2022-12-01)

Multiple myeloma with lung plasmacytoma
by: Rajendra Prasad, et al.
Published: (2011-01-01)

Negative E-cadherin expression on bone marrow myeloma cell membranes is associated with extramedullary disease [version 2; peer review: 2 approved]
by: Yutaka Hattori, et al.
Published: (2022-11-01)

Negative E-cadherin expression on bone marrow myeloma cell membranes is associated with extramedullary disease [version 1; peer review: 2 approved]
by: Yutaka Hattori, et al.
Published: (2022-02-01)

A novel two-step administration of XPO-1 inhibitor may enhance the effect of anti-BCMA CAR-T in relapsed/refractory extramedullary multiple myeloma
by: Di Wang, et al.
Published: (2023-11-01)